GB Patent

GB9204015D0 — Therapeutic nucleosides

Assigned to Wellcome Foundation Ltd · Expires 1992-04-08 · 34y expired

What this patent protects

The present invention relates to intermediates useful for the preparation of certain compounds, for example, purine carbocyclic nucleosides.

USPTO Abstract

The present invention relates to intermediates useful for the preparation of certain compounds, for example, purine carbocyclic nucleosides.

Drugs covered by this patent

Patent Metadata

Patent number: GB9204015D0
Jurisdiction: GB
Classification: —
Expires: 1992-04-08
Drug substance claim: No
Drug product claim: No
Assignee: Wellcome Foundation Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.